BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23864801)

  • 1. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.
    Park SK; Jung YK; Chung DH; Kim KK; Park YH; Lee JN; Kwon OS; Kim YS; Choi DJ; Kim JH
    Korean J Intern Med; 2013 Jul; 28(4):428-38. PubMed ID: 23864801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
    Ni Q; Jia H; Zhang Y; Lu J; Chang H
    Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.
    Sun LY; Cen WJ; Zeng XX; Zhong YY; Deng L; Yang JJ; Li M; Wang F
    Am Surg; 2024 Jun; 90(6):1240-1249. PubMed ID: 38214585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution.
    Kow AW; Kwon CH; Song S; Shin M; Kim JM; Joh JW
    Ann Surg Oncol; 2012 Jul; 19(7):2246-55. PubMed ID: 22402812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma.
    Shindoh J; Hasegawa K; Inoue Y; Ishizawa T; Nagata R; Aoki T; Sakamoto Y; Sugawara Y; Makuuchi M; Kokudo N
    HPB (Oxford); 2013 Jan; 15(1):31-9. PubMed ID: 23216777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion.
    Mai RY; Zeng J; Meng WD; Lu HZ; Liang R; Lin Y; Wu GB; Li LQ; Ma L; Ye JZ; Bai T
    BMC Cancer; 2021 Mar; 21(1):283. PubMed ID: 33726693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma.
    Kim JM; Kwon CH; Joh JW; Park JB; Ko JS; Lee JH; Kim SJ; Park CK
    World J Surg Oncol; 2013 Feb; 11():40. PubMed ID: 23432910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection.
    Polvieng T; Hongjinda S; Thienhiran A; Burasakarn P; Fuengfoo P
    Am Surg; 2024 Jun; 90(6):1447-1455. PubMed ID: 38516765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment.
    Gao J; Wang SH; Ding XM; Sun WB; Li XL; Xin ZH; Ning CM; Guo SG
    World J Gastroenterol; 2015 May; 21(17):5287-94. PubMed ID: 25954102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study.
    Iida H; Kaibori M; Hirokawa F; Inoue Y; Ueno M; Matsui K; Ishizaki M; Tanaka S; Takemura S; Nomi T; Hokutou D; Noda T; Eguchi H; Nakai T; Maehira H; Mori H; Tani M; Kubo S
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2903-2911. PubMed ID: 33112547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting overall survival and disease-free survival after surgery for hepatocellular carcinoma: a nomogram-based prognostic model-a Western European multicenter study.
    Masuda Y; Yeo MHX; Burdio F; Sanchez-Velazquez P; Perez-Xaus M; Pelegrina A; Koh YX; Di Martino M; Goh BKP; Tan EK; Teo JY; Romano F; Famularo S; Ferrari C; Griseri G; Piardi T; Sommacale D; Gianotti L; Molfino S; Baiocchi G; Ielpo B
    Updates Surg; 2024 Jan; 76(1):57-69. PubMed ID: 37839048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative Treatment.
    Mazza S; Frigerio C; Alfieri D; Mauro A; Torello Viera F; Scalvini D; Barteselli C; Sgarlata C; Veronese L; Bardone M; Rovedatti L; Agazzi S; Strada E; Pozzi L; Maestri M; Ravetta V; Anderloni A
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792876
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse impact of intermittent portal clamping on long-term postoperative outcomes in hepatocellular carcinoma.
    Hao S; Chen S; Yang X; Wan C
    Ann R Coll Surg Engl; 2017 Jan; 99(1):22-27. PubMed ID: 27269234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study.
    Zhang B; Xue J; Xu B; Chang J; Li X; Huang Z; Zhao H; Cai J
    Sci Rep; 2024 May; 14(1):10726. PubMed ID: 38730095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma.
    Jiang H; Qin Y; Wei H; Zheng T; Yang T; Wu Y; Ding C; Chernyak V; Ronot M; Fowler KJ; Chen W; Bashir MR; Song B
    Eur Radiol; 2024 May; 34(5):3163-3182. PubMed ID: 37870624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which factors predict tumor recurrence and survival after curative hepatectomy in hepatocellular carcinoma? Results from a European institution.
    Vaghiri S; Prassas D; Mustafov O; Kalmuk S; Knoefel WT; Lehwald-Tywuschik N; Alexander A; Dizdar L
    BMC Surg; 2024 Apr; 24(1):101. PubMed ID: 38589847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognosis after resection of cryptogenic hepatocellular carcinoma.
    Ohkura Y; Sasaki K; Matsuda M; Hashimoto M; Watanabe G
    BMC Surg; 2015 Oct; 15():115. PubMed ID: 26475278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
    Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
    Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
    Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.